In accordance with our prior findings [20], mid-region and NT1 assays measured the highest levels of tau in CSF, and we discovered that the NT1-tau assay perfectly discriminated CJD from both AD and controls. The gene discussed is MAPT; the disease is Creutzfeldt Jacob disease.